Parameters | Frequency (%) | SALL4 expression | P value | |
---|---|---|---|---|
< median | ≥median | |||
Age (n = 481) | ||||
< 60 | 222 (46.2) | 112 | 110 | 0.822 |
≥ 60 | 259 (53.8) | 128 | 131 | |
Sex (n = 481) | ||||
Male | 313 (65.1) | 148 | 165 | 0.118 |
Female | 168 (34.9) | 92 | 76 | |
T stage (n = 481) | ||||
T1 | 237 (49.3) | 133 | 104 | 0.003 |
T2 | 62 (12.9) | 35 | 27 | |
T3-T4 | 182 (37.8) | 73 | 109 | |
N stage (n = 224) | ||||
N0 | 207 (92.4) | 109 | 98 | 0.065 |
N1+ | 17 (7.6) | 5 | 12 | |
M stage(n = 461) | ||||
M0 | 390 (84.6) | 203 | 187 | 0.051 |
M1+ | 71 (15.4) | 28 | 43 | |
Tumor Grade (n = 455) | ||||
Grade 1–2 | 213 (2.0) | 122 | 91 | 0.003 |
Grade 3 | 176 (38.7) | 86 | 90 | |
Grade 4 | 66 (14.5) | 22 | 44 | |
AJCC stage (n = 436) | ||||
Stage I | 208 (47.7) | 116 | 92 | 0.047 |
Stage II | 48 (11.0) | 24 | 24 | |
Stage III | 110 (25.2) | 51 | 59 | |
Stage IV | 70 (16.1) | 26 | 44 |